{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T15:30:27Z","timestamp":1782055827220,"version":"3.54.5"},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1001\/jamadermatol.2020.3654","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T15:34:05Z","timestamp":1603294445000},"page":"1294","source":"Crossref","is-referenced-by-count":46,"title":["Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis"],"prefix":"10.1001","volume":"156","author":[{"given":"Hui Kai","family":"Koh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Fook-Chong","sequence":"additional","affiliation":[{"name":"Health Services Research Unit, Division of Medicine, Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haur Yueh","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10106","key":"doi200057r1","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs.","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"doi200057r2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"133","author":"Sekula","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"2","key":"doi200057r3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"2","key":"doi200057r4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.jid.5700068","article-title":"Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis.","volume":"126","author":"Gu\u00e9gan","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"10","key":"doi200057r5","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","article-title":"Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches.","volume":"137","author":"Gonz\u00e1lez-Herrada","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"3","key":"doi200057r6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.burns.2017.09.015","article-title":"Improving mortality outcomes of Stevens Johnson syndrome\/toxic epidermal necrolysis: A regional burns centre experience.","volume":"44","author":"Nizamoglu","year":"2018","journal-title":"Burns"},{"issue":"1","key":"doi200057r7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/BCR.0b013e31815f3865","article-title":"SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center.","volume":"29","author":"Cartotto","year":"2008","journal-title":"J Burn Care Res"},{"issue":"4","key":"doi200057r8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/jamadermatol.2018.5605","article-title":"Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis-ABCD-10.","volume":"155","author":"Noe","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi200057r9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"issue":"1","key":"doi200057r10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2016.07.048","article-title":"Cyclosporine treatment for Stevens-Johnson syndrome\/toxic epidermal necrolysis: retrospective analysis of a cohort treated in a specialized referral center.","volume":"76","author":"Lee","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi200057r11","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/bjd.12607","article-title":"The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre.","volume":"169","author":"Lee","year":"2013","journal-title":"Br J Dermatol"},{"key":"doi200057r12","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2019.1943","article-title":"The ABCD-10 risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis.","author":"Dhana","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi200057r13","doi-asserted-by":"crossref","first-page":"W1-73","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"issue":"7","key":"doi200057r14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jid.2016.03.023","article-title":"Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults.","volume":"136","author":"Hsu","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"6","key":"doi200057r15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jid.2017.01.031","article-title":"The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK.","volume":"137","author":"Frey","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"5","key":"doi200057r16","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/bjd.14934","article-title":"Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients.","volume":"176","author":"Papo","year":"2017","journal-title":"Br J Dermatol"},{"issue":"5","key":"doi200057r17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1468-3083.2012.04502.x","article-title":"SCORTEN and impaired renal function related to mortality of toxic epidermal necrolysis syndrome patients in the Asian population.","volume":"27","author":"Hu","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi200057r18","article-title":"Accuracy of SCORTEN to predict the prognosis of Stevens-Johnson syndrome\/toxic epidermal necrolysis: a systematic review and meta-analysis.","author":"Torres-Navarro","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"doi200057r19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaad.2014.07.016","article-title":"Retrospective review of Stevens-Johnson syndrome\/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.","volume":"71","author":"Kirchhof","year":"2014","journal-title":"J Am Acad Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2771824\/jamadermatology_koh_2020_oi_200057_1607046305.03257.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T01:24:37Z","timestamp":1607563477000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2771824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.3654","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}